BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2006
View Archived Issues
Chugai presents nonsteroidal androgen receptor antagonist for the treatment of prostate cancer
Read More
Snapshots of recent clinical trials in neuro-oncology
Read More
Glycolysis inhibition by 2-deoxy-D-glucose may be a novel antiepileptic strategy
Read More
Pfizer's orally active Cdk4/6 inhibitor PD-0332991 shows potential for myeloma therapy
Read More
Preclinical results suggest potential use of Pfizer's MEK inhibitor PD-0325901 in myeloid leukemia
Read More
ArQule updates program status
Read More
Intercell to acquire Pelias
Read More
AVX-13619 demonstrates antibacterial activity in systemic model
Read More
Avicena signs agreement with NINDS for phase III trial of PD-02
Read More
PanGenetics licenses antibody for treatment of pain from Lay Line Genomics
Read More
Xenon and Roche partner on protein therapeutics targeting hemojuvelin
Read More
Eltrombopag studied for ITP in long-term phase III study
Read More
rEV-131 fails to meet primary endpoint in phase IIb allergic rhinitis study
Read More
AC Immune and Genentech enter agreement for anti-beta-amyloid antibodies
Read More
Emergency contraceptive Ella begins phase III study
Read More
Lexapro provides greater reduction in MADRS scores than Cymbalta in MDD
Read More
PRTX-100 inhibits platelet phagocytosis in an in vitro model of ITP
Read More
Positive findings for Nastech's insulin nasal spray formulations
Read More
Iloperidone demonstrates statistical significance in schizophrenia
Read More
HuMax-CD20 produces positive ACR and EULAR responses in RA patients
Read More
Phenoxazine derivatives as new antimalarial drugs
Read More
Evista filed for reduction of invasive breast cancer in postmenopausal women
Read More
Velcade approved for relapsed mantle cell lymphoma
Read More
Orphan drug designation in renal cancer recommended for TroVax in E.U.
Read More
NDA submitted for telavancin in treatment of cSSSI
Read More
Recent patents reveal novel antiarthritic agents
Read More
Synordia European application withdrawn
Read More
Recent patents report new therapeutic agents for endocrine-related disorders
Read More
Novel agents for treating neurological disorders disclosed in recent Neuren and Santhera patents
Read More